DOSSIER · 13F Holders · Q3 2026Healthcare · Pharmaceutical Preparations
SPRY
ARS PHARMACEUTICALS INC
203 institutions still hold ARS PHARMACEUTICALS INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 82835W108·Pharmaceutical Preparations·203 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q3 2026
203 institutions reported SPRY in Q3 2026. DEERFIELD MANAGEMENT COMPANY, L.P. leads at 14.4% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 11
183 more holders available. Log in →